Update On Marginal Zone Lymphoma (MZL)

Listen Now

Topics Covered

• Overview of Marginal Zone Lymphoma (MZL), including Staging & Location, in the Context of COVID-19
• Subtypes of Marginal Zone Lymphoma
• Review of Treatment Options
• Treatment for Relapsed/Refractory Marginal Zone Lymphoma
• Managing Treatment Side Effects, Symptoms & Discomfort
• Key Questions to Ask Your Health Care Team
• The Important Role of Clinical Trials, in the Context of COVID-19
• How Research Contributes to Your Treatment Options
• The Increasing Role of Telehealth/Telemedicine Appointments
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions, & Discussion of OpenNotes
• Quality-of-Life Concerns & Follow-Up Care
• Questions for Our Panel of Experts

Our Panel of Experts

David J. Straus, MD

Attending Physician, Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Clinical Medicine, Weill Cornell Medical College

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on June 22, 2022.